Every SEC Form 3/4/5 on record for this filer (CIK 1630542) — 2 issuers, 9 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | Director | 2021-06-10 → 2025-09-10 | 6 | $1M |
| DROR | Dror Ortho-Design, Inc. | Director · lapsed | 2023-09-27 → 2024-06-25 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| NRXP | 2023-08-30 | Buy | 70,000 | $0.29 | $20,300 | 570,000 |
| NRXP | 2022-11-18 | Buy | 40,408 | $1.10 | $44,449 | 500,000 |
| NRXP | 2022-11-18 | Buy | 40,408 | $1.10 | $44,449 | 500,000 |
| NRXP | 2022-11-17 | Buy | 171,780 | $1.08 | $185,522 | 459,592 |
| NRXP | 2022-11-17 | Buy | 171,780 | $1.08 | $185,522 | 459,592 |
| NRXP | 2022-11-16 | Buy | 287,812 | $0.99 | $284,934 | 287,812 |
| NRXP | 2022-11-16 | Buy | 287,812 | $0.99 | $284,934 | 287,812 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.
